Catalyst Wire Dossier Catalyst Wire Dossier

Anti-PD-1/PD-L1 antibody

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-PD-1/PD-L1 antibody, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA

See pricing